Eye Movements: A Key to Supporting Pharmaceutical Research
Clinical highlights – November 2024 This month’s newsletter will highlight recent studies demonstrating how eye movement …
SfN 2024 eye movement research: your guide to navigating the annual meeting
Your guide to navigating the SfN 2024 annual meeting As you prepare for the SfN 2024 event, we’re here to help you make …
MDS 2024 Eye Movement Research: Your Guide to Navigating the Annual Meeting
Your guide to navigating the MDS 2024 annual meeting As you prepare for the MDS 2024 event, we’re here to help you make …
Clinical highlights: Multiple Sclerosis (MS) - neuroClues
Clinical highlights – August 2024 We are excited to share insights into the potential of eye tracking. Every month, we k …
Clinical highlights: Alzheimer’s Disease (AD)
Clinical highlights – July 2024 We are thrilled to inform you about the clinical benefits of eye tracking. Every month, …
Clinical Get Together 2024 – Recap
Clinical Get Together 2024 Welcome to the recap of our recent scientific evening, held in conjunction with the JNLF 2024 …
neuroClues® secures €5 million to launch its groundbreaking technology, set to support the early diagnosis of Parkinson’s disease and other neurological disorders
Paris, April 30, 2024 – neuroClues®, a French-Belgian medtech company specializing in the diagnosis of neurodegenerative …
ISO 13485:2016 certification for design & development
In summary P3Lab, a European startup founded in 2020 is developing NeuroClues®, a medical device based on eye tracking t …
